4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001209191-15-043036
Director acquired 1,850,464 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CLARKE JOHN K Director | 2015-05-12 | Conversion | +92,306 | 104,878 | D | ||
| CLARKE JOHN K Director | 2015-05-12 | Conversion | +1,758,158 | 1,758,158 | I | ||
| Derivatives | |||||||
| CLARKE JOHN K Director | 2015-05-12 | Conversion · Series E Redeemable Convertible Preferred Stock | −893,655 | 0 | D | ||
| CLARKE JOHN K Director | 2015-05-12 | Conversion · Series A Redeemable Convertible Preferred Stock | −2,400,000 | 0 | I | ||
| CLARKE JOHN K Director | 2015-05-12 | Conversion · Series B Redeemable Convertible Preferred Stock | −3,600,000 | 0 | I | ||
| CLARKE JOHN K Director | 2015-05-12 | Conversion · Series B-2 Redeemable Convertible Preferred Stock | −4,320,173 | 0 | I | ||
| CLARKE JOHN K Director | 2015-05-12 | Conversion · Series C Redeemable Convertible Preferred Stock | −2,127,660 | 0 | I | ||
| CLARKE JOHN K Director | 2015-05-12 | Conversion · Series D Redeemable Convertible Preferred Stock | −1,536,787 | 0 | I | ||
Loading xslF345X03/doc4.xml…